AWKN — Awakn Life Sciences Balance Sheet
0.000.00%
Last trade - 00:00- CA$4.85m
- CA$4.72m
- CA$0.09m
Annual balance sheet for Awakn Life Sciences, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0.366 | 1.62 | 0.551 | 0.407 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.018 | 0.13 | 0.143 | 0.021 |
| Prepaid Expenses | ||||
| Total Current Assets | 0.477 | 2.11 | 0.975 | 0.496 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.349 | 3.61 | 2.95 | 0.001 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 0.825 | 6.88 | 4.39 | 0.543 |
| Payable / Accrued | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.242 | 1.86 | 2.46 | 2.07 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 0.498 | 3.46 | 3.55 | 2.07 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 0.328 | 3.41 | 0.848 | -1.53 |
| Total Liabilities & Shareholders' Equity | 0.825 | 6.88 | 4.39 | 0.543 |
| Total Common Shares Outstanding |